DSM-5: Substance Related and Addictive Disorders
Charles P. O'Brien, M.D., Ph.D.
Center for Studies of Addiction
Professor, Department of Psychiatry
University of Pennsylvania School of Medicine
Tuesday, January 14, 2014
This presentation will focus on key changes to the substance use disorders chapter of DSM-5. The rationale for changes in the substance use disorder classification and select criteria includes the need to address longstanding problems that resulted from DSM-IV's approach to diagnosis and the need to better integrate new research findings, which themselves underscored the importance of revising the old classification. New disorders will be described, along with proposed disorders that currently do not have adequate replicated findings in the peer-reviewed literature to support their inclusion of Section II of DSM-5, and thus are listed in DSM-5's Section III. Going forward, revisions to this and other diagnostic areas may be more readily implemented as soon as scientific evidence supports doing so, rather than requiring an extended, set period of time to pass, as occurred with the changes from DSM-IV to DSM-5.